BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38675428)

  • 1. Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta.
    Calenda S; Catarzi D; Varano F; Vigiani E; Volpini R; Lambertucci C; Spinaci A; Trevisan L; Grieco I; Federico S; Spalluto G; Novello G; Salmaso V; Moro S; Colotta V
    Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.
    Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V
    Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
    Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems.
    Grieco I; Bissaro M; Tiz DB; Perez DI; Perez C; Martinez A; Redenti S; Mariotto E; Bortolozzi R; Viola G; Cozza G; Spalluto G; Moro S; Federico S
    Eur J Med Chem; 2021 Apr; 216():113331. PubMed ID: 33721670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δ Inhibitors.
    Cescon E; Bolcato G; Federico S; Bissaro M; Valentini A; Ferlin MG; Spalluto G; Sturlese M; Moro S
    ACS Med Chem Lett; 2020 Jun; 11(6):1168-1174. PubMed ID: 32550997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zebrafish as model system for the biological characterization of CK1 inhibitors.
    Meier L; Gahr BM; Roth A; Gihring A; Kirschner S; Woitaske-Proske C; Baier J; Peifer C; Just S; Knippschild U
    Front Pharmacol; 2023; 14():1245246. PubMed ID: 37753113
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent Advances in the Development of Casein Kinase 1 Inhibitors.
    Li SS; Dong YH; Liu ZP
    Curr Med Chem; 2021; 28(8):1585-1604. PubMed ID: 32660395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Dual Anta-Inhibitors" of the A
    Spinaci A; Buccioni M; Catarzi D; Cui C; Colotta V; Dal Ben D; Cescon E; Francucci B; Grieco I; Lambertucci C; Marucci G; Bassani D; Pavan M; Varano F; Federico S; Spalluto G; Moro S; Volpini R
    Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ.
    Bolcato G; Cescon E; Pavan M; Bissaro M; Bassani D; Federico S; Spalluto G; Sturlese M; Moro S
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
    García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
    J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between a point mutation S97C in CK1δ protein and its affect on ATP-binding affinity.
    Kumar A; Rajendran V; Sethumadhavan R; Purohit R
    J Biomol Struct Dyn; 2014; 32(3):394-405. PubMed ID: 23527964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1δ and ε with nanomolar inhibitory activity on cancer cell proliferation.
    Richter J; Bischof J; Zaja M; Kohlhof H; Othersen O; Vitt D; Alscher V; Pospiech I; García-Reyes B; Berg S; Leban J; Knippschild U
    J Med Chem; 2014 Oct; 57(19):7933-46. PubMed ID: 25191940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening.
    Cozza G; Gianoncelli A; Montopoli M; Caparrotta L; Venerando A; Meggio F; Pinna LA; Zagotto G; Moro S
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5672-5. PubMed ID: 18799313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.
    Cheong JK; Nguyen TH; Wang H; Tan P; Voorhoeve PM; Lee SH; Virshup DM
    Oncogene; 2011 Jun; 30(22):2558-69. PubMed ID: 21258417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinase activity of casein kinase 1 delta (CK1δ) is modulated by protein kinase C α (PKCα) by site-specific phosphorylation within the kinase domain of CK1δ.
    Meng Z; Böhm T; Xu P; Henne-Bruns D; Peifer C; Witt L; Knippschild U; Bischof J
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):710-721. PubMed ID: 31096047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Protein Kinase CK1δ with Riluzole: Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View?
    Bissaro M; Federico S; Salmaso V; Sturlese M; Spalluto G; Moro S
    ChemMedChem; 2018 Dec; 13(24):2601-2605. PubMed ID: 30359484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.
    Richter J; Ullah K; Xu P; Alscher V; Blatz A; Peifer C; Halekotte J; Leban J; Vitt D; Holzmann K; Bakulev V; Pinna LA; Henne-Bruns D; Hillenbrand A; Kornmann M; Leithäuser F; Bischof J; Knippschild U
    Int J Cancer; 2015 Jun; 136(12):2799-810. PubMed ID: 25404202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation.
    Ianes C; Xu P; Werz N; Meng Z; Henne-Bruns D; Bischof J; Knippschild U
    Amino Acids; 2016 Feb; 48(2):579-92. PubMed ID: 26464264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CK1δ kinase activity is modulated by Chk1-mediated phosphorylation.
    Bischof J; Randoll SJ; Süßner N; Henne-Bruns D; Pinna LA; Knippschild U
    PLoS One; 2013; 8(7):e68803. PubMed ID: 23861943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.